Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome.

PubWeight™: 1.59‹?› | Rank: Top 4%

🔗 View Article (PMID 11346322)

Published in Ann Intern Med on May 01, 2001

Authors

F Creed1, J Ratcliffe, L Fernandez, B Tomenson, S Palmer, C Rigby, E Guthrie, N Read, D Thompson

Author Affiliations

1: School of Psychiatry and Behavioural Science, Rawnsley Building, Oxford Road, Manchester M13 9WL, United Kingdom.

Associated clinical trials:

Brain-Gut Interactions in Overweight and Normal Weight Patients With Chronic Abdominal Pain | NCT00824941

Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients | NCT01916200

Articles citing this

Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87

Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol (2014) 2.30

Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut (2007) 2.28

A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D). Gut (2015) 1.55

Health care charges for youth with newly diagnosed epilepsy. Neurology (2015) 1.49

Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life. World J Gastroenterol (2004) 1.20

Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14

Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver (2011) 1.12

Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS). BMC Gastroenterol (2007) 1.10

Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS. Aliment Pharmacol Ther (2012) 1.05

How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice. BMC Gastroenterol (2010) 1.00

Cost-effectiveness of acupuncture for irritable bowel syndrome: findings from an economic evaluation conducted alongside a pragmatic randomised controlled trial in primary care. BMC Gastroenterol (2012) 0.96

A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life. ISRN Gastroenterol (2010) 0.93

The association of mast cells and serotonin in children with chronic abdominal pain of unknown etiology. BMC Res Notes (2010) 0.89

Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol (2016) 0.87

Incidence and psychological-behavioral characteristics of refractory functional dyspepsia: a large, multi-center, prospective investigation from China. World J Gastroenterol (2015) 0.87

Health related quality of life in functional gastrointestinal disorders in Asia. J Neurogastroenterol Motil (2011) 0.86

Effect of childhood adversity on health related quality of life in patients with upper abdominal or chest pain. Gut (2004) 0.84

The treatment of irritable bowel syndrome. Therap Adv Gastroenterol (2009) 0.84

Illness perceptions mediate the relationship between bowel symptom severity and health-related quality of life in IBS patients. Qual Life Res (2015) 0.84

Cost-utility analysis of lopinavir/ritonavir versus atazanavir + ritonavir administered as first-line therapy for the treatment of HIV infection in Italy: from randomised trial to real world. PLoS One (2013) 0.82

Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449]. Nutr J (2006) 0.81

Sleep quality, BDNF genotype and gene expression in individuals with chronic abdominal pain. BMC Med Genomics (2014) 0.80

Stress and gene expression of individuals with chronic abdominal pain. Biol Res Nurs (2012) 0.80

Functional illness in primary care: dysfunction versus disease. BMC Fam Pract (2008) 0.80

So-eum type as an independent risk factor for irritable bowel syndrome: a population-based study in Korea. J Altern Complement Med (2014) 0.80

Maladjustment to Academic Life and Employment Anxiety in University Students with Irritable Bowel Syndrome. PLoS One (2015) 0.78

Patient knowledge and perspective on irritable bowel syndrome: development of a survey instrument. Dig Dis Sci (2007) 0.77

Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome. World J Gastroenterol (2011) 0.77

An Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium. Gastroenterol Hepatol (N Y) (2010) 0.77

A protocol for a trial of homeopathic treatment for irritable bowel syndrome. BMC Complement Altern Med (2012) 0.77

Point of Care Ultrasound Accurately Distinguishes Inflammatory from Noninflammatory Disease in Patients Presenting with Abdominal Pain and Diarrhea. Can J Gastroenterol Hepatol (2016) 0.76

Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterol Res Pract (2016) 0.75

Epidemiology of irritable bowel syndrome. Ann Gastroenterol (2015) 0.75

The mind-body connection in irritable bowel syndrome: A randomised controlled trial of hypnotherapy as a treatment. Health Psychol Open (2015) 0.75

Comparison of medical costs generated by IBS patients in primary and secondary care in the Netherlands. BMC Gastroenterol (2015) 0.75

Variation in Care for Patients with Irritable Bowel Syndrome in the United States. PLoS One (2016) 0.75

An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-D. Gastroenterol Hepatol (N Y) (2013) 0.75

Common Functional Gastroenterological Disorders Associated With Abdominal Pain. Mayo Clin Proc (2016) 0.75

Economic burden of irritable bowel syndrome in China. World J Gastroenterol (2016) 0.75

Linaclotide: a novel therapy for chronic constipation and constipation-predominant irritable bowel syndrome. Gastroenterol Hepatol (N Y) (2012) 0.75

The global impact of IBS: time to think about IBS-specific models of care? Therap Adv Gastroenterol (2017) 0.75

Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland. Eur J Health Econ (2016) 0.75

[Irritable bowel syndrome]. Schmerz (2004) 0.75

Articles by these authors

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet (2005) 6.18

Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet (1995) 5.79

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry (2005) 4.86

Rhizobium phaseoli symbiotic mutants with transposon Tn5 insertions. J Bacteriol (1984) 4.09

Management of deliberate self poisoning in adults in four teaching hospitals: descriptive study. BMJ (1998) 3.68

Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients. Ann Intern Med (1998) 3.55

Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev (2001) 3.46

Randomised controlled trial of brief psychological intervention after deliberate self poisoning. BMJ (2001) 3.46

BMI from 3-6 y of age is predicted by TV viewing and physical activity, not diet. Int J Obes (Lond) (2005) 2.99

Marinobacter hydrocarbonoclasticus gen. nov., sp. nov., a new, extremely halotolerant, hydrocarbon-degrading marine bacterium. Int J Syst Bacteriol (1992) 2.96

Provision of intensive care for children. A geographically integrated service may now be achieved. BMJ (1998) 2.76

Psychological factors in the irritable bowel syndrome. Gut (1987) 2.73

The metabolism of 5-fluorocytosine-2-14-C and of cytosine-14-C in the rat and the disposition of 5-fluorocytosine-2-14-C in man. Biochem Pharmacol (1966) 2.72

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature (2002) 2.71

The impact of long-term acute-care facilities on the outcome and cost of care for patients undergoing prolonged mechanical ventilation. Crit Care Med (2000) 2.66

Bacterial infection in cystic fibrosis. Arch Dis Child (1972) 2.58

Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. J Virol (2008) 2.56

Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clin Infect Dis (2010) 2.51

Altruism by proxy: volunteering children for bone marrow donation. BMJ (1996) 2.50

A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology (1991) 2.48

Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA (1997) 2.46

Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial. Arch Intern Med (2000) 2.46

Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res (2001) 2.45

A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology (2000) 2.44

Embarking upon a medical career: psychological morbidity in first year medical students. Med Educ (1995) 2.28

Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain. Health Technol Assess (2005) 2.21

Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group. Seizure (1999) 2.18

Community care and criminal offending in schizophrenia. Lancet (2000) 2.13

Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther (1984) 2.12

Should we be doing more to prevent Group C meningococcal infection in school age children? How can we decide? J Public Health Med (1999) 2.11

British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut (2000) 2.09

Depression and social stress in Pakistan. Psychol Med (2000) 2.09

Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. Am J Med Genet (1994) 2.06

The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess (2006) 2.04

Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis (1990) 2.04

Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res (1987) 2.03

[The reason for medical consultations in patients with psychiatric diseases: somatization phenomena and suicide attempts]. Med Clin (Barc) (1997) 2.03

Report on hypertension. Can Med Assoc J (1978) 2.01

Outcome of anxiety and depressive disorders in primary care. Br J Psychiatry (1997) 1.98

Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci (1988) 1.96

Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res (1999) 1.95

Prevalence of anxiety and depressive illness and help seeking behaviour in African Caribbeans and white Europeans: two phase general population survey. BMJ (1999) 1.94

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91

Transforming the tobacco market: why the supply of cigarettes should be transferred from for-profit corporations to non-profit enterprises with a public health mandate. Tob Control (2005) 1.88

Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Mol Biochem Parasitol (1989) 1.87

Randomized clinical trial comparing surgery with conservative treatment for uncomplicated varicose veins. Br J Surg (2006) 1.87

A robust measure of HIV-1 population turnover within chronically infected individuals. Mol Biol Evol (2004) 1.87

A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer (2006) 1.86

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N Engl J Med (1998) 1.81

Sudden death in psychiatric patients. Br J Psychiatry (1998) 1.81

The shaken infant syndrome. BMJ (1995) 1.81

The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group. J Clin Oncol (1993) 1.79

Chamber formation and morphogenesis in the developing mammalian heart. Dev Biol (2000) 1.77

Immunological analysis of the skin in graft versus host disease. Clin Exp Immunol (1982) 1.76

Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes. Br J Psychiatry Suppl (2002) 1.75

Survival, morbidity, and quality of life after discharge from intensive care. Crit Care Med (2000) 1.75

Prospective audit of surgery for varicose veins. Br J Surg (1997) 1.73

Rationale, design and methods for process evaluation in the HEALTHY study. Int J Obes (Lond) (2009) 1.70

Deliberating about bioethics. Hastings Cent Rep (1997) 1.69

Metabolism of diazepam in rat, dog, and man. J Pharmacol Exp Ther (1965) 1.69

Contribution of depression and anxiety to impaired health-related quality of life following first myocardial infarction. Br J Psychiatry (2006) 1.68

The evolution of the emergency care practitioner role in England: experiences and impact. Emerg Med J (2006) 1.65

A short pseudoautosomal region in laboratory mice. Genome Res (2001) 1.64

Rationale, design and methods of the HEALTHY study behavior intervention component. Int J Obes (Lond) (2009) 1.61

Plasma D-dimer: a useful tool for evaluating suspected pulmonary embolus. J Nucl Med (1993) 1.59

A survey of Campylobacter and other bacterial contaminants of pre-market chicken and retail poultry and meats, King County, Washington. Am J Public Health (1986) 1.59

Herpes zoster encephalomyelitis associated with low dose methotrexate for rheumatoid arthritis. J Rheumatol (1997) 1.58

Reducing risk by improving standards of intrapartum fetal care. J R Soc Med (2001) 1.58

Applied behavior analysis in the treatment of childhood feeding problems. Dev Med Child Neurol (1975) 1.57

Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. J Pediatr (1991) 1.55

Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis. Health Technol Assess (2009) 1.54

A prospective randomized study of 4.1 French catheters utilizing the percutaneous right brachial approach for the diagnosis of coronary artery disease. Cathet Cardiovasc Diagn (1992) 1.53

A descriptive analysis of children's playground injuries in the United States 1990-4. Inj Prev (1997) 1.52

Constructing deletions with defined endpoints in Drosophila. Proc Natl Acad Sci U S A (1990) 1.51

The effects of dothiepin on subjects with rheumatoid arthritis and depression. Rheumatology (Oxford) (1999) 1.51

Surgical revascularisation for childhood moyamoya. Childs Nerv Syst (2012) 1.51

Comparison of genome screens for two independent cohorts provides replication of suggestive linkage of bone mineral density to 3p21 and 1p36. Am J Hum Genet (2002) 1.51

Tetanus in a dog. Vet Rec (1989) 1.49

Rapid accumulation of inositol phosphates in isolated rat superior cervical sympathetic ganglia exposed to V1-vasopressin and muscarinic cholinergic stimuli. Biochem J (1984) 1.49

Structural analysis of membrane-bound retrovirus capsid proteins. EMBO J (1997) 1.48

Mass hysteria: one syndrome or two? Br J Psychiatry (1996) 1.48

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer (2006) 1.48

Serious criminal offending and mental disorder. Case linkage study. Br J Psychiatry (1998) 1.45

Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol (1998) 1.43

Common errors and controversies in pharmacoeconomic analyses. Pharmacoeconomics (1998) 1.43

Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis (2004) 1.43

GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res (1996) 1.42

Depression in old age. A reconsideration of cerebral disease in relation to outcome. Br J Psychiatry (1993) 1.42

Baroreceptor, not left ventricular, dysfunction is the cause of hemodialysis hypotension. Clin Nephrol (1989) 1.40

Cutaneous findings in a new syndrome of autosomal recessive ectodermal dysplasia with corkscrew hairs. J Am Acad Dermatol (1992) 1.40

Persistent vomiting in patients with diabetes. Diabet Med (2000) 1.39

She died at home--all possible support. Community Outlook (1979) 1.39

A randomised controlled trial of psychotherapy in patients with refractory irritable bowel syndrome. Br J Psychiatry (1993) 1.38

Differences in the regulation of endothelin-1- and lysophosphatidic-acid-stimulated Ins(1,4,5)P3 formation in rat-1 fibroblasts. Biochem J (1991) 1.37

Lifetime health and economic benefits of weight loss among obese persons. Am J Public Health (1999) 1.37

Cyclosporin A, methylprednisolone, and convulsions. Lancet (1982) 1.37

Early onset baldness and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2000) 1.37